FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cord Blood
Cord Blood Registry Advances Leadership Position in Growing Family Cord Blood Banking Industry
March 15th, 2007
Cord Blood Registry(R) (CBR), the world's leading, privately-held, umbilical cord blood stem cell bank, today stated it will exceed $100 million in revenues before the end of 2007. CBR will be the first in the industry to reach this milestone. CBR's enrollments and revenue have increased every year since inception and the company has generated positive cash flow from operations since 1999. In addition, the company continues to grow its market share position, which is currently more than 40 percent higher than the nearest competitor. CBR chief executive officer Tom Moore credits the company's financial performance on the key strategic investments and...
Source: FDA Law Weekly (2007-03-15)
|
